Data as of May 24
| +0.08 / +2.22%|
The 5 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +63.04% increase from the last price of 3.68.
The current consensus among 6 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.